DDX3L Inhibitors
DDX3L inhibitors encompass a variety of compounds that indirectly impact the protein's role in RNA metabolism, particularly in translation and RNA processing. Compounds such as Hippuristanol, Pateamine A, Rocaglamide, Silvestrol, Tetracycline, Emetine, Cycloheximide, Puromycin, Anisomycin, Chloramphenicol, Camptothecin, and Actinomycin D target various stages of the RNA translation process or RNA synthesis. These inhibitors primarily function by disrupting translation initiation or elongation, thereby indirectly reducing DDX3L's involvement in these processes. For instance, inhibitors targeting eIF4A, such as Hippuristanol and Pateamine A, affect translation initiation, a stage where DDX3L is known to play a role. By inhibiting this initiation process, these compounds indirectly reduce the functional activity of DDX3L in RNA translation.
Additionally, compounds that interfere with protein synthesis at different stages, like Emetine, Cycloheximide, and Puromycin, contribute to the overall reduction in DDX3L's functional activity. These inhibitors impact the translational machinery, leading to a decrease in the efficiency of processes in which DDX3L participates. Furthermore, compounds like Camptothecin and Actinomycin D, which affect DNA and RNA synthesis, can also indirectly influence DDX3L's activity in RNA processing. By altering the transcription and processing of RNA, these compounds can lead to a reduced functional role of DDX3L in these pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Rocaglamide acts as an inhibitor of translation initiation, particularly targeting eIF4A. Its inhibitory effect on translation initiation can indirectly decrease the functional activity of DDX3L in RNA processing. | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
Silvestrol, an inhibitor of eIF4A, can indirectly inhibit DDX3L by disrupting the translation initiation complex. This inhibition of translation initiation can lead to decreased functional activity of DDX3L in RNA translation. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
Tetracycline, known for its antibiotic properties, can also affect protein synthesis. By interfering with translation, it can indirectly inhibit the functional activity of DDX3L in RNA processing. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Emetine, an inhibitor of eukaryotic protein synthesis, can indirectly inhibit DDX3L by disrupting the translation process in which DDX3L participates. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis at the translation stage. This inhibition can indirectly decrease DDX3L's functional activity related to RNA translation. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin, an inhibitor of protein synthesis, can indirectly reduce DDX3L's activity in RNA processing by disrupting the translation mechanism. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin interferes with protein synthesis by inhibiting peptidyl transferase. This action can indirectly reduce the functional activity of DDX3L in RNA-related processes. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $90.00 | 10 | |
Chloramphenicol inhibits bacterial protein synthesis but can also affect eukaryotic mitochondria. It can indirectly influence DDX3L's role in RNA processing by affecting translation. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin, known for inhibiting DNA topoisomerase I, can indirectly impact RNA processing pathways in which DDX3L is involved, potentially leading to reduced helicase activity. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D inhibits DNA-dependent RNA synthesis and can indirectly inhibit DDX3L by affecting RNA processing and transcription regulation. | ||||||